keyword
https://read.qxmd.com/read/38493509/shorter-versus-longer-duration-of-antimicrobial-therapy-for-early-lyme-disease-a-systematic-review-and-meta-analysis
#21
JOURNAL ARTICLE
Maria Meritxell Roca Mora, Luisa Marin Cunha, Amanda Godoi, Isabelle Donadon, Mariana Clemente, Patrícia Marcolin, Andres Valenzuela S, Gary P Wormser
BACKGROUND: Antibiotic therapy for patients with early Lyme disease is necessary to prevent later-stage Lyme disease complications. This systematic review and meta-analysis compares shorter versus longer antibiotic regimens in treating early Lyme disease. METHODS: A systematic search of PubMed, Embase, and Cochrane Central Register of Controlled Trials was conducted up to November 2023. We examined treatment failure, complete response, and photosensitivity. Short vs...
February 15, 2024: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/38458336/chronic-sexually-acquired-reactive-arthritis-secondary-to-chlamydiatrachomatis
#22
JOURNAL ARTICLE
Arkendu Basu, Jaya Biswas, Saurabh Singh, Vishal Gupta, Benu Dhawan
Reactive arthritis is included in the spectrum of seronegative spondyloarthritides, occurring secondary to triggers of genitourinary and gastrointestinal tract infections. We describe two cases of sexually acquired reactive arthritis secondary to genital infection by Chlamydia trachomatis, diagnosed by in-house polymerase chain reaction performed on the first void urine. Both patients were managed with a combined approach of short course antibiotics, immunosuppressive agents, biologicals and surgical intervention...
March 6, 2024: Indian Journal of Medical Microbiology
https://read.qxmd.com/read/38455816/a-case-of-gemella-morbillorum-causing-multi-valvular-endocarditis
#23
Gabriel Panama, Adolfo Martinez, Majid Yavari, Andrew Geunwon Kim, George Abela
This is the case of a 31-year-old man with no significant past medical history who presented to the emergency department experiencing persistent fevers, chills, and malaise for the past 2-3 weeks. During this period, he had multiple urgent care visits for possible left-sided otitis media which was treated with short a course of Augmentin. While on antibiotics his symptoms would improve, but they would reappear once he had finished treatment. The patient also had significant dental carries with a chronic right molar infection...
February 2024: Curēus
https://read.qxmd.com/read/38452051/vancomycin-nephrotoxicity-a-comprehensive-clinico-pathological-study
#24
JOURNAL ARTICLE
Rajesh Nachiappa Ganesh, Angelina Edwards, Ziad El Zaatari, Lillian Gaber, Roberto Barrios, Luan D Truong
INTRODUCTION: Vancomycin, a commonly prescribed antibiotic particularly in the setting of multi-drug resistant infections, is limited by its nephrotoxicity. Despite its common occurrence, much remains unknown on the clinicopathologic profile as well as the pathogenesis of vancomycin nephrotoxicity. Clinical studies included patients often with severe comorbidities and concomitant polypharmacy confounding the causal pathogenesis. Animal models cannot recapitulate this complex clinical situation...
2024: PloS One
https://read.qxmd.com/read/38451294/shorter-versus-longer-course-of-antibiotic-therapy-for-urinary-tract-infections-in-pediatric-population-an-updated-meta-analysis
#25
REVIEW
Marcus Vinicius Barbosa Moreira, Lucas Rezende de Freitas, Luiza Mendes Fonseca, Matheus Jose Barbosa Moreira, Caroline Cristine Almeida Balieiro, Isabela Reis Marques, Paula Chaves Mari
Urinary tract infections (UTI) affect between 3% to 7.5% of the febrile pediatric population each year, being one of the most common bacterial infections in pediatrics. Nevertheless, there is no consensus in the medical literature regarding the duration of per oral (p.o.) antibiotic therapy for UTI among these patients. Therefore, our meta-analysis aims to assess the most effective therapy length in this scenario. PubMed, Cochrane, and Embase were searched for randomized controlled trials (RCTs) comparing short (≤ 5 days) with long-course (≥ 7 days) per os (p...
March 7, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38420157/association-of-short-course-antimicrobial-therapy-and-bacterial-resistance-in-acute-cholangitis-retrospective-cohort-study
#26
JOURNAL ARTICLE
Sakue Masuda, Ryuhei Jinushi, Yoshinori Imamura, Jun Kubota, Karen Kimura, Kento Shionoya, Makomo Makazu, Ryo Sato, Makoto Kako, Masahiro Kobayashi, Haruki Uojima, Kazuya Koizumi
Background and study aims Although the number of resistant bacteria tends to increase with prolonged antimicrobial therapy, no studies have examined the relationship between the duration of antimicrobial therapy and increase in the number of resistant bacteria in acute cholangitis. We hypothesized that the short-term administration of antimicrobial agents in acute cholangitis would suppress bacterial resistance. Patients and methods This was a single-center, retrospective, observational study of patients with acute cholangitis admitted between January 2018 and June 2020 who met the following criteria: successful biliary drainage, positive blood or bile cultures, bacteria identified from cultures sensitive to antimicrobials, and subsequent cholangitis recurrence by January 2022...
February 2024: Endoscopy International Open
https://read.qxmd.com/read/38407831/antibiotics-for-patients-with-a-planned-re-laparotomy-for-intra-abdominal-infection
#27
JOURNAL ARTICLE
Lauren J Hochstetler, William J Olney, Jacqueline M Bishop, Zachary D Warriner, Jeremy D VanHoose, Ryan P Mynatt, Dina Ali, Aric Schadler, Sara E Parli
Background: Appropriate antimicrobial therapy for the management of intra-abdominal infection (IAI) continues to evolve based on available literature. The Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial provided evidence to support four days of antibiotic agents in IAI post-source control but excluded patients with a planned re-laparotomy. This study aimed to determine the short- and long-term recurrent infection risk in this population. Patients and Methods: This is a single-center, retrospective, observational study of adult patients admitted to a quaternary medical center between January 1, 2016, and August 1, 2022, with IAI requiring planned laparotomy...
February 26, 2024: Surgical Infections
https://read.qxmd.com/read/38406563/constructing-an-osseointegrated-prosthetic-leg
#28
JOURNAL ARTICLE
Haris Kafedzic, S Robert Rozbruch, Taylor J Reif, Jason S Hoellwarth
BACKGROUND: Constructing an osseointegrated prosthetic leg is the necessary subsequent phase of care for patients following the surgical implantation of an osseointegrated prosthetic limb anchor. The surgeon implants the bone-anchored transcutaneous implant1,2 and the prosthetist constructs the prosthetic leg, which then attaches to the surgically implanted anchor. An osseointegration surgical procedure is usually considered in patients who are unable to use or are dissatisfied with the use of a socket prosthesis...
2024: JBJS Essential Surgical Techniques
https://read.qxmd.com/read/38361718/improvement-of-recalcitrant-dissecting-cellulitis-of-the-scalp-after-a-trial-of-upadacitinib
#29
Zahidul Islam, Michelle Toker, Isha M Gandhi, Ariel Sher, Kristina Campton
Dissecting cellulitis of the scalp (DCS) is a rare condition characterized by painful inflammatory nodules and abscesses on the scalp, often leading to sinus tracts and scarring alopecia. We present a case of DCS in a 26-year-old male who experienced significant clinical improvement following a short course of upadacitinib, a Janus kinase (JAK) inhibitor. The patient received multiple standard treatments such as topical antimicrobials, oral antibiotics, corticosteroids, and intralesional triamcinolone injections, with limited success...
January 2024: Curēus
https://read.qxmd.com/read/38347703/evaluation-of-short-versus-long-courses-of-antibiotics-in-critically-ill-patients-with-gram-negative-bloodstream-infections
#30
JOURNAL ARTICLE
Daniel T Anderson, Divisha Sharma, Aaron M Chase, Zoheb Irshad Sulaiman, August H Anderson, Ashley L Huggett, Joshua Eudy
BACKGROUND: Short courses of antibiotics (7-10 days) are effective for uncomplicated gram-negative bloodstream infections (GN-BSI). However, prior studies have been limited to small cohorts of critically ill patients. OBJECTIVE: The objective of this study was to evaluate the safety and efficacy of short courses of therapy compared with longer courses in patients admitted to the intensive care unit (ICU) with GN-BSI. METHODS: Propensity-matched, retrospective cohort study of critically ill patients with GN-BSI...
February 12, 2024: Annals of Pharmacotherapy
https://read.qxmd.com/read/38344512/urgent-cesarean-section-in-a-patient-on-venovenous-extracorporeal-membrane-oxygenation
#31
Daniela Havens-Lastarria, Sara K Biladeau, Daniel Haines, Ryan Grell
A G7P6 40-year-old female at 20 weeks gestation, with a history of polysubstance use disorder and hepatitis C, presented to the emergency department with severe shortness of breath and hypoxia requiring intubation. After a thorough workup, she was diagnosed with aspiration pneumonitis and was treated with a course of antibiotics. After progressing well, she was soon extubated and transferred to a subacute rehabilitation facility (SAR). There, she acutely decompensated, requiring readmission, reintubation, and venovenous extracorporeal membrane oxygenation (ECMO) cannulation...
January 2024: Curēus
https://read.qxmd.com/read/38332590/efficacy-and-safety-of-short-vs-standard-course-antibiotics-for-culture-negative-neonatal-sepsis-a-systematic-review-and-meta-analysis
#32
JOURNAL ARTICLE
Risha Devi, Mayank Priyadarshi, Poonam Singh, Suman Chaurasia, Sriparna Basu
OBJECTIVES: To conduct a systematic review and meta-analysis of evidence from randomized controlled trials (RCTs) comparing a short course of antibiotics (2-4 days), to a standard course (5-7 days), for the treatment of culture-negative neonatal sepsis. METHODS: Relevant databases were searched for RCTs comparing short- vs. standard-course of antibiotics for culture-negative sepsis. The primary outcomes were mortality and treatment failure, defined as the reappearance of clinical signs suggestive of sepsis within 7 days of stoppage of antibiotics...
February 7, 2024: Journal of Tropical Pediatrics
https://read.qxmd.com/read/38310450/an-update-to-novel-therapeutic-options-for-combating-tuberculosis-challenges-and-future-prospectives
#33
JOURNAL ARTICLE
Swathi Suresh, Rukaiah Fatma Begum, Ankul Singh S, Chitra Vellapandian
Drug repurposing is an ongoing and clever strategy that is being developed to eradicate tuberculosis amid challenges, of which one of the major challenges is the resistance developed towards antibiotics used in standard directly observed treatment, short-course regimen. Surpassing the challenges in developing anti-tuberculous drugs, some novel host-directed therapies, repurposed drugs, and drugs with novel targets are being studied, and few are being approved too. After almost 4 decades since the approval of rifampicin as a potent drug for drugsusceptible tuberculosis, the first drug to be approved for drug-resistant tuberculosis is bedaquiline...
January 16, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38310448/role-of-nutraceuticals-in-treating-erectile-dysfunction-via-inhibition-of-phosphodiesterase-5-enzyme-a-mini-review
#34
JOURNAL ARTICLE
Rashi Kulshrestha, Neelam Singla, Obaid Afzal, Ahsas Goyal, Mahendra Saini, Abdulmalik Saleh Alfawaz Altamimi, Waleed Hassan Almalki, Imran Kazmi, Fahad Al-Abbasi, Sami I Alzarea, Gaurav Gupta
Drug repurposing is an ongoing and clever strategy that is being developed to eradicate tuberculosis amid challenges, of which one of the major challenges is the resistance developed towards antibiotics used in standard directly observed treatment, short-course regimen. Surpassing the challenges in developing anti-tuberculous drugs, some novel host-directed therapies, repurposed drugs, and drugs with novel targets are being studied, and few are being approved too. After almost 4 decades since the approval of rifampicin as a potent drug for drugsusceptible tuberculosis, the first drug to be approved for drug-resistant tuberculosis is bedaquiline...
January 16, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38299825/resistance-mechanism-and-fitness-cost-of-specific-bacteriophages-for-pseudomonas-aeruginosa
#35
JOURNAL ARTICLE
Luozhu Feng, Huanchang Chen, Changrui Qian, Yining Zhao, Weixiang Wang, Yan Liu, Mengxin Xu, Jianming Cao, Tieli Zhou, Qing Wu
The bacteriophage is an effective adjunct to existing antibiotic therapy; however, in the course of bacteriophage therapy, host bacteria will develop resistance to bacteriophages, thus affecting the efficacy. Therefore, it is important to describe how bacteria evade bacteriophage attack and the consequences of the biological changes that accompany the development of bacteriophage resistance before the bacteriophage is applied. The specific bacteriophage vB3530 of Pseudomonas aeruginosa ( P. aeruginosa ) has stable biological characteristics, short incubation period, strong in vitro cleavage ability, and absence of virulence or resistance genes...
February 1, 2024: MSphere
https://read.qxmd.com/read/38286962/can-the-evidence-based-use-of-probiotics-notably-saccharomyces-boulardii-cncm-i-745-and-lactobacillus-rhamnosus-gg-mitigate-the-clinical-effects-of-antibiotic-associated-dysbiosis
#36
JOURNAL ARTICLE
Dan Waitzberg, Francisco Guarner, Iva Hojsak, Gianluca Ianiro, D Brent Polk, Harry Sokol
Dysbiosis corresponds to the disruption of a formerly stable, functionally complete microbiota. In the gut, this imbalance can lead to adverse health outcomes in both the short and long terms, with a potential increase in the lifetime risks of various noncommunicable diseases and disorders such as atopy (like asthma), inflammatory bowel disease, neurological disorders, and even behavioural and psychological disorders. Although antibiotics are highly effective in reducing morbidity and mortality in infectious diseases, antibiotic-associated diarrhoea is a common, non-negligible clinical sign of gut dysbiosis (and the only visible one)...
January 30, 2024: Advances in Therapy
https://read.qxmd.com/read/38280768/management-of-ventilator-associated-pneumonia-guidelines
#37
REVIEW
Mark L Metersky, Andre C Kalil
Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP...
March 2024: Infectious Disease Clinics of North America
https://read.qxmd.com/read/38272050/individualised-short-course-antibiotic-treatment-versus-usual-long-course-treatment-for-ventilator-associated-pneumonia-regard-vap-a-multicentre-individually-randomised-open-label-non-inferiority-trial
#38
JOURNAL ARTICLE
Yin Mo, Suchart Booraphun, Andrew Yunkai Li, Pornanan Domthong, Gyan Kayastha, Yie Hui Lau, Ploenchan Chetchotisakd, Direk Limmathurotsakul, Paul Anantharajah Tambyah, Ben S Cooper
BACKGROUND: Ventilator-associated pneumonia (VAP) is associated with increased mortality, prolonged hospitalisation, excessive antibiotic use and, consequently, increased antimicrobial resistance. In this phase 4, randomised trial, we aimed to establish whether a pragmatic, individualised, short-course antibiotic treatment strategy for VAP was non-inferior to usual care. METHODS: We did an individually randomised, open-label, hierarchical non-inferiority-superiority trial in 39 intensive care units in six hospitals in Nepal, Singapore, and Thailand...
January 22, 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38271205/exploratory-pilot-studies-to-demonstrate-mechanisms-of-preventing-antibiotic-associated-diarrhea-and-the-role-for-probiotics
#39
RANDOMIZED CONTROLLED TRIAL
Daniel Merenstein, Tina Tan, Keisha Herbin Smith
Context: Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. One of the most common indications for probiotic treatment is the prevention of antibiotic-associated diarrhea (AAD). Unfortunately, many probiotic products used for AAD are not supported by rigorous independent research, and often results in non-evidence-based usage. Additionally, it is not clear when is the most appropriate time to take a probiotic when on an antibiotic course. Objectives: The primary aim is to determine the ability of BB-12 to impact antibiotic-induced reduction in short chain fatty acid concentration (SCFA), as reflected by the levels of acetate on day 14...
November 1, 2024: Annals of Family Medicine
https://read.qxmd.com/read/38199745/a-37-year-old-man-with-dyspnea-bilateral-lung-consolidation-and-a-tracheal-mass
#40
Rohit Shirgaonkar, Manoj Kumar Panigrahi, Aswathy Girija, Prity Sharma, Preetam Chappity, Sagar Ranjan Tripathy
A 37-year-old man presented to the ED with symptoms of productive cough, self-reported fever, and shortness of breath for the past 15 days. He was placed on noninvasive mechanical ventilation for respiratory distress. IV piperacillin-tazobactam and inhaled bronchodilators were promptly administered, and he was subsequently transferred to the respiratory ICU for further care. He had no history of bowel and bladder disturbance, altered sensorium, swelling of feet, or abdominal distention. He never used tobacco and denied a history of TB...
January 2024: Chest
keyword
keyword
165541
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.